| scholarly article | Q13442814 |
| P356 | DOI | 10.18632/ONCOTARGET.24196 |
| P8608 | Fatcat ID | release_fxc54id6xfbmdkg5wzbzzphkne |
| P932 | PMC publication ID | 5823560 |
| P698 | PubMed publication ID | 29492219 |
| P2093 | author name string | Gianluigi Giannelli | |
| Vito Guerra | |||
| Anna Maria Valentini | |||
| Maria Lucia Caruso | |||
| Federica Di Pinto | |||
| Filomena Cariola | |||
| Michele Pirrelli | |||
| P2860 | cites work | Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target | Q24559442 |
| Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer | Q24685406 | ||
| The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
| The emerging role of immunotherapy in colorectal cancer | Q28067898 | ||
| Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others | Q28072468 | ||
| PD-L1 and Survival in Solid Tumors: A Meta-Analysis | Q28084090 | ||
| PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
| Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer | Q28245751 | ||
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients | Q29617771 | ||
| Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy | Q29617774 | ||
| Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape | Q29620881 | ||
| Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
| Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability | Q33786764 | ||
| Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis | Q34147688 | ||
| Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies | Q34362289 | ||
| PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer | Q34778769 | ||
| Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. | Q34809019 | ||
| The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints | Q34943776 | ||
| Tissue expression of PD-L1 mediates peripheral T cell tolerance. | Q36228541 | ||
| The PD-1-PD-L pathway in immunological tolerance | Q36405777 | ||
| Colorectal cancer carcinogenesis: a review of mechanisms | Q36849645 | ||
| Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types. | Q36939402 | ||
| Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer. | Q37697218 | ||
| Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading. | Q38610333 | ||
| Microsatellite Instability as a Biomarker for PD-1 Blockade | Q38735093 | ||
| Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway | Q38996832 | ||
| Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity | Q39026688 | ||
| Neutrophils as active regulators of the immune system in the tumor microenvironment | Q39164353 | ||
| Immune Checkpoints as a Target for Colorectal Cancer Treatment. | Q39387816 | ||
| Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. | Q39930421 | ||
| PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes | Q40745198 | ||
| Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability | Q40850728 | ||
| Immune checkpoint blockade in microsatellite instable colorectal cancers: Back to the clinic | Q41593422 | ||
| Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers | Q42275171 | ||
| Immunotherapy resistance: the answers lie ahead - not in front - of us. | Q42320552 | ||
| Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma. | Q42721528 | ||
| Morphology of sporadic colorectal cancer with DNA replication errors | Q43087650 | ||
| Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma | Q43282875 | ||
| Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma | Q44698673 | ||
| Impact of immune parameters on long-term survival in metastatic renal cell carcinoma | Q44811646 | ||
| Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma | Q45054030 | ||
| PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry | Q47781498 | ||
| Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas | Q48942904 | ||
| Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. | Q50757104 | ||
| Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. | Q50876217 | ||
| Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. | Q53281128 | ||
| Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. | Q54269172 | ||
| Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. | Q54628312 | ||
| IL-18 Induces PD-1-Dependent Immunosuppression in Cancer | Q57556330 | ||
| New monoclonal antibodies against B-cell antigens: Possible new strategies for diagnosis of primary cutaneous B-cell lymphomas | Q58482097 | ||
| PD-1: an inhibitory immunoreceptor involved in peripheral tolerance | Q73807451 | ||
| Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection | Q82641830 | ||
| Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance | Q82793374 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 8584-8596 | |
| P577 | publication date | 2018-01-12 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments. | |
| P478 | volume | 9 |
| Q89610924 | Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor Models |
| Q63729383 | Immunoprofiles of colorectal cancer from Lynch syndrome |
| Q60961676 | Increased nerve twigs in small intestinal mucosa with programmed cell death-ligand 1 and somatostatin receptor type 2A expression in recurrent Crohn disease: A case report |
| Q91394247 | Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression |
| Q92875307 | Mechanisms of immunogenicity in colorectal cancer |
| Q92035014 | Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features |
| Q98159002 | PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer |
| Q92721786 | PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus |
| Q92839298 | Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients |
| Q64268768 | The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status |
| Q92684094 | Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status |
Search more.